Evidence map›Paper›PMID 31812180›Full record

ReviewThe Journal of allergy and clinical immunology2019

The role of the changing human microbiome in the asthma pandemic.

Timothy C Borbet, Xiaozhou Zhang, Anne Müller, Martin J Blaser

Abstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Mucins and Their Roles in Asthma.Immunological reviews · 2025
    Review
  5. Review
  6. Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  7. Article
  8. What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Environmental Microbiome, Allergic Disease, and Asthma.The journal of allergy and clinical immunology. In practice · 2022
    Article
  14. Microbiome-based therapeutics.Nature reviews. Microbiology · 2022
    Review
  15. Article
  16. Article
  17. Relationship betweenFrontiers in cellular and infection microbiology · 2022
    Review
  18. Impact of intestinal flora on calcium oxalate stones.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timothy C BorbetDepartment of Pathology, New York University School of Medicine, New York, NY.
Xiaozhou ZhangInstitute of Molecular Cancer Research, Zurich, Switzerland.
Anne MüllerInstitute of Molecular Cancer Research, Zurich, Switzerland. Electronic address: mueller@imcr.uzh.ch.
Martin J BlaserCenter for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ. Electronic address: martin.blaser@cabm.rutgers.edu.

Funding

NRSA Training CoreTL1TR001447 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICOLI, KEITH J. · 2015 to 2025
$5.9M
Microbial, immune, metabolic perturbations by antibiotics (MIME study)U01AI122285 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MARTIN J BLASER, Steven M Holland · 2016 to 2026
$5.2M
NCATS NIH HHS TL1 TR001447NIAID NIH HHS U01 AI122285
6 · The paper itself

Abstract

Asthma and allergy incidence continue to increase globally. We have made significant strides in treating disease, but it is becoming more apparent that we need to advance our knowledge into the origins of asthmatic disease. Much recent work has indicated that microbiome composition influences immune regulation and that multiple health care factors have driven a loss in microbiome diversity in modern human populations. Evidence is growing of microbiota-driven influences on immune development, asthma susceptibility, and asthma pathogenesis. The focus of this review is to highlight the strides the field has made in characterizing the constituents of the human gastrointestinal microbiota, such as Helicobacter pylori, other members of the neonatal intestinal microbiota, and microbial peptides and metabolites that influence host immunity and immune response to allergens. As we delve further into this field of research, the goal will be to find actionable and clinical interventions to identify at-risk populations earlier to prevent disease onset. Manipulation of the host microbial community during infancy might be an especially promising approach.

Indexed as

AsthmaAllergensDisease SusceptibilityHelicobacter pyloriHumansMicrobiotaPandemicsRisk FactorsAllergensallergyAsthmaHelicobacter pylorimicrobiome

Identifiers

PMID31812180
PMCPMC6905199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.